Ceruloplasmin expression was also dramatically downregulated in non-triple-negative breast cancer (TNBC) and non-basal-like BRCA patients compared with that in basal-like and TNBC BRCA patients (Figure 3F–3H). The gene discussed is CP; the disease is triple-negative breast carcinoma.